Lineage Cell Therapeutics, Inc.
LCTX
Revenue
1.41M
▼-36.00k▼-2.49%
3 Months ChangeAssets
102.80M
▼-5.68M▼-5.24%
3 Months ChangeLiabilities
35.93M
▼-1.57M▼-4.18%
3 Months ChangeFree Cash Flow
-5.82M
▲5.61M▲49.07%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-094004
2024-08-08
Form 8-K
ID: 0000950170-24-093947
2024-06-14
Form 8-K
ID: 0000950170-24-073769
2024-06-13
Form 8-K
ID: 0000950170-24-073072
2024-05-14
Form 8-K
ID: 0000950170-24-059689
2024-05-09
Form 10-Q
ID: 0000950170-24-056998
2024-05-09
Form 8-K
ID: 0000950170-24-056948
2024-03-22
Form 8-K
ID: 0000950170-24-035365
2024-03-07
Form 8-K
ID: 0000950170-24-027951
2024-02-15
Form 8-K
ID: 0001493152-24-006901